Skip to main content
Figure 2 | Journal of Experimental & Clinical Cancer Research

Figure 2

From: Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas

Figure 2

The increasing levels of antibodies to SH3GL1 in sera of the patients with low-grade glioma. Serum antibody level to SH3GL1 was examined by the ELISA as described in the legends of Figure1. First screening test (A) and the individual validation test (B), revealed the significant higher levels of autologous antibody against SH3GL1 in low-grade glioma patients, than healthy donors (P = 0.045 and 0.0189).

Back to article page